Peritoneal dialysis nursing: cloudy effluent and peritonitis red flags

Peritoneal dialysis (PD) is a home-based form of renal replacement therapy that uses the peritoneal membrane as a natural filter. Instead of routing blood through an external machine, dialysate fluid is instilled into the abdominal cavity, where solutes and excess fluid pass across the peritoneum into the solution by osmosis and diffusion. The dialysate is then drained, carrying waste products with it. PD was used by 12.1% of prevalent U.S. dialysis patients in 2022, and 14.0% of incident patients started on it (2024 USRDS Annual Data Report) – far less common than hemodialysis in the hospital setting, but highly testable on the NCLEX because of its unique complications, sterile technique demands, and patient education requirements. Students who understand PD are also better prepared to compare and differentiate dialysis modalities, a classic NCLEX question type.

This article covers the complete peritoneal dialysis skill set: catheter care, CAPD vs CCPD mechanics, the exchange procedure step by step, dialysate glucose concentrations, nursing assessment priorities, and a full complications table with NCLEX-priority nursing actions.

Types of peritoneal dialysis

Three modalities exist under the PD umbrella. The NCLEX focuses primarily on CAPD and CCPD, and expects you to know what distinguishes them operationally.

CAPD – continuous ambulatory peritoneal dialysis

CAPD is the original home PD modality. The patient performs four manual exchanges per day – typically morning, noon, late afternoon, and bedtime. Each exchange takes 30–40 minutes: 20 minutes to drain the old dialysate, 10 minutes to infuse the new bag, and a 4–6 hour dwell in between. During the dwell, the patient is fully ambulatory – hence “ambulatory.” No machine is required, only gravity and sterile technique.

CAPD is suitable for patients who can reliably perform sterile technique and can commit to four exchanges daily. It offers continuous solute clearance, which better mimics physiological kidney function than intermittent hemodialysis.

CCPD – continuous cycling peritoneal dialysis

CCPD uses an automated cycler machine to perform multiple rapid exchanges overnight while the patient sleeps, typically over 8–10 hours. The patient connects to the machine at bedtime, and disconnects in the morning – sometimes with dialysate left in the abdomen for a daytime dwell. “Continuous” refers to the fact that dialysis is ongoing (overnight cycling plus daytime dwell), distinguishing it from older intermittent methods. CCPD is often preferred by working patients or those who struggle with four daily manual exchanges.

APD – automated peritoneal dialysis

APD is the broader category that includes CCPD and other cycler-based regimens. The terms are used interchangeably in many clinical settings. When the NCLEX says “APD,” think: cycler machine, overnight, automated.

The Tenckhoff catheter

All peritoneal dialysis requires a permanent intraperitoneal access device. The Tenckhoff catheter is the most common type – a silicone tube surgically placed through the abdominal wall into the peritoneal cavity, with one or two subcutaneous Dacron cuffs that anchor it in place and form a bacterial barrier. The external portion exits through the skin at the exit site, typically in the lower abdomen.

What the nurse must know

• Placement timing: Catheter is typically placed 2–4 weeks before dialysis begins, to allow the exit site to heal and the cuffs to fibrose
• No bending or twisting: Catheter kinking obstructs flow and can cause both drain failure and fill failure
• Never pull on the catheter: Tension can displace or dislodge the tip from the pelvis
• Not a vascular access device: The PD catheter enters the peritoneal space, not a blood vessel – never draw blood, infuse medications, or check central venous pressure through it

Exit site care

Exit-site and tunnel infections can spread to the peritoneum and lead to catheter loss. The 2023 ISPD catheter-related infection update sets a target of no more than 0.40 exit-site infections per patient-year at risk. Daily care is non-negotiable:

1. Inspect the exit site daily for erythema, swelling, tenderness, or purulent discharge
2. Clean with chlorhexidine or povidone-iodine per facility protocol (preferences vary by center)
3. Apply a topical antibiotic (mupirocin or gentamicin) if the program uses one – common practice, though ISPD 2023 downgraded this recommendation
4. Apply a sterile dressing and secure the catheter to prevent traction
5. Document appearance at each assessment – early changes matter

Exchange procedure (CAPD) – step by step

The CAPD exchange is the core nursing skill for peritoneal dialysis. Each step exists for a reason; the NCLEX tests whether you know what can go wrong and why. Every exchange requires strict sterile technique – the peritoneal cavity is a closed space with no inherent defenses against introduced organisms.

Step 1 – Prepare the environment. Wash hands thoroughly with soap and water as taught in PD training (CDC advises scrubbing for at least 20 seconds) and dry them completely. Close windows and doors to minimize airflow. Turn off fans and air conditioning vents in the room. Gather all supplies: dialysate bag (correct volume and glucose concentration), drain bag, transfer set, mask.

Step 2 – Don masks. Both the patient and the nurse wear surgical masks throughout the exchange. Respiratory droplets are a direct contamination pathway to the catheter connection – this is a frequently tested NCLEX point.

Step 3 – Inspect the dialysate bag. Before connecting anything, check: expiration date, bag integrity (no leaks or punctures), dialysate clarity (should be clear – particulate or cloudiness in the new bag indicates a manufacturing defect, discard it), glucose concentration (confirm it matches the prescription), and volume.

Step 4 – Warm the dialysate. Dialysate should be warmed to body temperature (approximately 37°C / 98.6°F) before instillation. Cold dialysate causes abdominal cramping and reduces ultrafiltration efficiency. Warm using a heating pad or commercial warmer – never microwave a dialysate bag, which creates uneven hot spots.

Step 5 – Connect the outflow bag and drain. Using sterile non-touch technique, connect the transfer set to the catheter and open the outflow clamp. Gravity drives the old dialysate into the drain bag. Drain phase takes approximately 20 minutes. Elevating the drain bag above the patient’s abdomen will stop flow – it must remain below the patient.

Step 6 – Inspect the effluent. Before proceeding to fill, examine the drained dialysate. Normal effluent is clear to slightly yellow. Cloudy effluent indicates peritonitis until proven otherwise – collect a sample for culture and sensitivity before starting antibiotics. Other findings: bloody effluent (hemoperitoneum – concerning if new or heavy), fibrin strands (common, not peritonitis – may obstruct catheter, add heparin to dialysate per protocol), brown effluent (fecal contamination – bowel perforation, emergency).

Step 7 – Connect the new dialysate bag and fill. Close the outflow clamp, open the inflow clamp. Dialysate flows into the peritoneal cavity by gravity over approximately 10 minutes. The patient should feel mild fullness but not pain. Pain during fill suggests catheter tip malposition, or rarely, chemical peritonitis.

Step 8 – Dwell. Close all clamps. For CAPD, the dwell phase lasts 4–6 hours. During this time, solutes (urea, creatinine, potassium, phosphorus) diffuse from blood into dialysate across the peritoneal membrane. Water moves by osmosis toward the dialysate, driven by the dextrose gradient.

Step 9 – Disconnect and cap. Using sterile technique, disconnect the transfer set and apply a sterile cap to the catheter. Document the exchange: dialysate concentration used, volume instilled, volume drained (note the difference – this is the ultrafiltration volume), and effluent appearance.

Dialysate glucose concentrations

PD relies on dextrose as the osmotic agent. Higher dextrose concentration = greater osmotic gradient = more water removed (ultrafiltration). Understanding the concentrations is directly tested on the NCLEX.

Key NCLEX point: 4.25% dextrose provides the most ultrafiltration but also causes the most glucose absorption into the bloodstream. In diabetic patients, this can produce significant hyperglycemia and require insulin dose adjustment. Icodextrin is a polymer-based osmotic agent used as a glucose-sparing alternative for long dwells.

Nursing assessment priorities

Every PD patient requires a structured assessment at each clinical encounter. The following are the NCLEX-priority parameters.

Fluid balance: Weigh the patient daily on the same scale. Weight gain between exchanges reflects inadequate ultrafiltration or dietary fluid excess. Calculate net ultrafiltration by subtracting volume instilled from volume drained – a positive number (more out than in) confirms fluid removal. Monitor blood pressure bilaterally for hypertension (fluid overload) or hypotension (excess ultrafiltration).

Exit site: Inspect at every visit. The exit site should be clean, dry, and non-tender. Early identification of redness or discharge prevents progression to tunnel infection and catheter loss. Document findings precisely – changes from previous assessment are what matter.

Effluent clarity: This is the most time-sensitive assessment. Check every drain bag. Cloudy = peritonitis until proven otherwise – do not wait for labs to act.

Symptoms of peritoneal infection: Abdominal pain, rebound tenderness, nausea, vomiting, fever, and malaise in a PD patient are peritonitis until the culture says otherwise. Peritonitis is the leading cause of catheter loss and technique failure in PD patients.

Nutritional status: Protein crosses the peritoneal membrane and is lost in every exchange. Albumin and pre-albumin levels trend downward in poorly nourished PD patients. Ensure dietary protein intake of 1.0–1.2 g/kg/day (KDOQI 2020).

Blood glucose: Relevant in all PD patients – even non-diabetics absorb meaningful amounts of glucose from 2.5% and 4.25% dextrose solutions. Diabetic patients on PD require blood glucose monitoring before and after long dwells and may need insulin added directly to the dialysate.

Catheter function: Assess for adequate drain and fill flow. Poor flow (slow drain, incomplete fill) suggests kinking, fibrin occlusion, or tip migration. Ambulating the patient after a slow drain often restores flow – bowel motility moves the catheter tip back into position.

Complications

PD complications fall into infectious and mechanical categories. All of them are testable. The table below organizes them by type with the nursing priority action for each.

Peritonitis in depth: the most feared complication

Peritonitis deserves extended coverage because it is the NCLEX’s highest-yield PD topic and the complication most likely to result in catheter loss, hospitalization, or modality switch to hemodialysis.

Pathophysiology: Organisms enter the peritoneal space almost always through the catheter connection during an exchange – touch contamination, respiratory droplets, or breaks in sterile technique. Less commonly, infection tracks up the catheter from an exit site or tunnel infection (inside-out route), or enters transmurally from bowel (think: diverticulitis, ruptured viscus).

Diagnosis: The 2022 ISPD (International Society for Peritoneal Dialysis) criteria require at least two of three: (1) clinical features – abdominal pain and/or cloudy effluent; (2) effluent white cell count above 100/µL (0.1 × 10⁹/L) after a dwell of at least 2 hours, with more than 50% polymorphonuclear cells; (3) positive effluent culture. ISPD recommends treating cloudy effluent as peritonitis until it is ruled out.

Sample collection: Send the drained effluent for cell count with differential, Gram stain, and culture and sensitivity. This must be done before starting antibiotics. A culture after antibiotic exposure often returns false-negative and delays targeted therapy.

Treatment: ISPD 2022 recommends starting empiric antibiotics as soon as specimens are collected and prefers the intraperitoneal (IP) route, added directly to the dialysate, unless the patient has signs of systemic sepsis. Regimens are center-specific and cover both gram-positive organisms (first-generation cephalosporin or vancomycin) and gram-negative organisms (third-generation cephalosporin or aminoglycoside). Gram-positive skin organisms, including coagulase-negative staphylococci and S. aureus, are common causes. Treatment length depends on the organism: 2 weeks for coagulase-negative staphylococci, streptococci and culture-negative episodes that respond, and 3 weeks for S. aureus and Pseudomonas. ISPD also recommends antifungal prophylaxis whenever a PD patient receives antibiotics, because fungal peritonitis (usually Candida) requires immediate catheter removal. Programs aim for fewer than 0.40 peritonitis episodes per patient-year.

PD during treatment: PD is not stopped during peritonitis treatment. Dialysis continues – the antibiotic is added to each dialysate bag. Stopping PD during peritonitis would deny the patient renal replacement therapy without clinical benefit.

Catheter removal: Indications include refractory peritonitis (effluent that fails to clear after 5 days of appropriate antibiotics; ISPD 2022 allows a longer trial if the effluent white count is falling), fungal peritonitis, tunnel infection extending to the inner cuff, fecal peritonitis (bowel perforation), and mycobacterial peritonitis.

Hemodialysis vs peritoneal dialysis: NCLEX comparison

NCLEX questions often ask students to choose the correct statement about HD vs PD, or to identify which modality is appropriate for a given patient. This table covers the key differentiators.

For the NCLEX, the highest-yield comparison points are: PD preserves residual renal function better, requires no anticoagulation, is performed at home, and carries peritonitis risk that HD does not. HD is preferred when abdominal surgery or extensive adhesions compromise the peritoneal surface.

Patient education: what every PD patient must know

The PD patient is their own primary nurse. Technique failures cause peritonitis. Effective patient education is a nursing responsibility and an NCLEX topic.

Sterile technique is not optional. Every exchange connection and disconnection must be performed with meticulous aseptic technique. Most peritonitis episodes are directly traceable to contamination during the exchange – a dropped cap, a forgotten mask, a touch to the catheter tip.

Inspect every dialysate bag before use. Check the expiration date, bag integrity, and clarity. A cloudy new bag goes in the trash, not into the patient.

Recognize peritonitis early. Patients must know to call immediately if the drained dialysate is cloudy, if they develop abdominal pain, or if they develop fever. Early treatment prevents catheter loss.

Exit site care daily. Clean the exit site every day regardless of whether an exchange is scheduled. Any change from baseline appearance – increased redness, swelling, pain, or discharge – warrants a call to the dialysis team.

Diet. Eat enough protein – about 1.0 to 1.2 g/kg/day, as set by the renal dietitian. Protein lost across the peritoneal membrane must be replaced through diet. Unlike hemodialysis patients, PD patients have somewhat more liberal potassium and phosphorus limits because of continuous clearance, but individualized dietary guidance from a renal dietitian remains essential.

Medication interactions. Some medications alter PD efficacy or carry increased risks in patients with renal failure. Electrolyte imbalances remain a concern even with PD, and patients should not take potassium supplements or potassium-sparing agents without guidance.

NCLEX tips: 14 high-yield peritoneal dialysis facts

Peritoneal dialysis generates reliable NCLEX questions because it tests sterile technique, clinical reasoning around complications, and the ability to differentiate PD from hemodialysis. These 14 points cover the highest-yield material.

1. Cloudy effluent = peritonitis until proven otherwise. This is the single most tested PD fact on the NCLEX. Cloudy drain fluid is never “probably fine” – it is peritonitis until culture results say otherwise.

2. Collect the effluent sample BEFORE starting antibiotics. Culture after antibiotic exposure frequently returns false-negative. The sample must be sent first.

3. Both patient and nurse wear masks during every exchange. Respiratory droplets directly contaminate the catheter connection. This is non-negotiable and frequently appears as a distractor question.

4. Warm the dialysate before instillation. Cold dialysate causes abdominal cramping and reduces ultrafiltration. Body temperature is the target. Never microwave – use a heating pad or commercial warmer.

5. 4.25% dextrose = maximum ultrafiltration, maximum glucose absorption. It is not for routine use. Know that higher dextrose concentration removes more fluid but delivers more glucose into the bloodstream.

6. Icodextrin is used for long overnight dwells and reduces glucose exposure. Its maltose metabolite causes falsely high readings on GDH-PQQ and some other glucose meters, so a patient can be hypoglycemic while the meter reads normal or high, and insulin given on that reading can be dangerous. Use only glucose-specific meters or lab methods (Extraneal label).

7. Drain before you fill – always. The outflow (drain) phase comes before the inflow (fill) phase. Reversing the order would add dialysate volume to an already-filled abdomen.

8. Fibrin strands in effluent are common and not peritonitis. Add heparin to the dialysate per protocol to prevent catheter obstruction from fibrin clots. Do not confuse fibrin with the cloudiness of peritonitis.

9. PD catheter is NOT a vascular access device. Never draw blood, infuse IV fluids, or give IV medications through a PD catheter.

10. PD preserves residual renal function better than hemodialysis. This is a classic NCLEX differentiation point. Continuous low-flux clearance is less injurious to remaining nephrons than intermittent high-flux hemodialysis.

11. Anticoagulation is NOT required for PD. Blood never contacts an extracorporeal circuit. Heparin is only added to dialysate if fibrin clots are present in effluent.

12. Ambulating the patient often resolves slow drain flow. Catheter tip migration into the wrong peritoneal position is corrected by movement – bowel peristalsis shifts the tip back toward the pelvis.

13. Hydrothorax presents as sudden dyspnea with right-sided pleural effusion. Dialysate crosses a diaphragmatic defect. Confirm by glucose content of pleural fluid (higher than serum = dialysate). Management: stop or reduce PD, surgical repair.

14. PD patients need about 1.0–1.2 g/kg/day of protein (KDOQI 2020). Protein loss across the peritoneal membrane is ongoing and significant. Hypoalbuminemia in a PD patient should prompt a nutritional assessment before assuming another cause.

Connecting the clinical picture

Peritoneal dialysis nursing intersects with several other clinical areas you will encounter in training and on the NCLEX. Patients who arrive at PD typically have CKD/ESRD as the underlying diagnosis, or have progressed from AKI that did not recover. Understanding PD alongside hemodialysis nursing gives you the comparative framework the NCLEX tests. The sterile technique principles that govern PD exchanges mirror those required for urinary catheterization and other invasive procedures – same rationale, different anatomy. Peritonitis prevention is fundamentally an infection control problem, and the same principles that govern transmission-based precautions (barriers, hand hygiene, environmental control) apply directly to the PD exchange environment. Finally, electrolyte imbalances continue to be a monitoring priority even in patients on PD – continuous clearance reduces but does not eliminate the risk of hyperkalemia, hyperphosphatemia, and metabolic acidosis.

PD is a therapy that demands clinical precision from both nurse and patient. The mechanism is elegant – the body’s own membrane doing the work of the kidney – but the margin for technique error is narrow. Master the exchange procedure, commit the complications table to memory, and understand what makes PD different from hemodialysis. That foundation covers the core of what the NCLEX will ask.

References

1. Li PK, Chow KM, Cho Y, et al. ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment. Perit Dial Int. 2022;42(2):110–153. doi:10.1177/08968608221080586 [Supersedes the 2016 update, Perit Dial Int. 2016;36(5):481–508]
2. Bargman JM, Thorpe KE, Churchill DN; CANUSA Peritoneal Dialysis Study Group. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol. 2001;12(10):2158–2162. doi:10.1681/ASN.V12102158
3. Piraino B, Bailie GR, Bernardini J, et al. Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int. 2005;25(2):107–131. doi:10.1177/089686080502500203 [Historical; superseded by refs 1 and 16]
4. Mehrotra R, Devuyst O, Davies SJ, Johnson DW. The current state of peritoneal dialysis. J Am Soc Nephrol. 2016;27(11):3238–3252. doi:10.1681/ASN.2016010112
5. Johnson DW, Brown FG, Clarke M, et al; balANZ Trial Investigators. Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes. J Am Soc Nephrol. 2012;23(6):1097–1107. doi:10.1681/ASN.2011121201
6. Mujais S, Nolph K, Gokal R, et al. Evaluation and management of ultrafiltration problems in peritoneal dialysis. Perit Dial Int. 2000;20(Suppl 4):S5–S21.
7. Davies SJ. Mitigating peritoneal membrane characteristics in modern peritoneal dialysis therapy. Kidney Int Suppl. 2006;(103):S76–S83. doi:10.1038/sj.ki.5001920
8. Paniagua R, Amato D, Vonesh E, et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol. 2002;13(5):1307–1320. doi:10.1681/ASN.V1351307
9. Lo WK, Ho YW, Li CS, et al. Effect of Kt/V on survival and clinical outcome in CAPD patients in a randomized prospective study. Kidney Int. 2003;64(2):649–656. doi:10.1046/j.1523-1755.2003.00098.x
10. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105(4S):S117–S314. doi:10.1016/j.kint.2023.10.018 [Supersedes the KDIGO 2012 CKD guideline]
11. Twardowski ZJ, Nolph KD, Khanna R, et al. The need for a “swan neck” permanently bent, arcuate peritoneal dialysis catheter. Perit Dial Bull. 1985;5(4):219–223.
12. Cho Y, Johnson DW. Peritoneal dialysis-related peritonitis: towards improving evidence, practices, and outcomes. Am J Kidney Dis. 2014;64(2):278–289. doi:10.1053/j.ajkd.2014.02.025
13. Krediet RT, Balafa O. Cardiovascular risk in the peritoneal dialysis patient. Nat Rev Nephrol. 2010;6(8):451–460. doi:10.1038/nrneph.2010.68
14. Blake PG, Bargman JM, Brimble KS, et al. Clinical practice guidelines and recommendations on peritoneal dialysis adequacy 2011. Perit Dial Int. 2011;31(2):218–239. doi:10.3747/pdi.2011.00026
15. Woodrow G, Davies S. Renal Association clinical practice guideline on peritoneal dialysis. Nephron Clin Pract. 2011;118(Suppl 1):c287–c310. doi:10.1159/000328073
16. Chow KM, Li PK, Cho Y, et al. ISPD catheter-related infection recommendations: 2023 update. Perit Dial Int. 2023;43(3):201–219. doi:10.1177/08968608231172740
17. Ikizler TA, Burrowes JD, Byham-Gray LD, et al. KDOQI clinical practice guideline for nutrition in CKD: 2020 update. Am J Kidney Dis. 2020;76(3 Suppl 1):S1–S107. doi:10.1053/j.ajkd.2020.05.006
18. United States Renal Data System. 2024 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2024. https://usrds-adr.niddk.nih.gov/2024
19. Baxter Healthcare. EXTRANEAL (icodextrin) peritoneal dialysis solution: prescribing information (boxed warning and section 5.1, glucose monitoring). DailyMed setid d5b85158-b0d6-4855-9d07-8d1b3ad9ab71. Accessed October 13, 2026.